Hydrocortisone

Description

Walgreens Anti Itch spray is formulated to provide relief from itching associated with minor skin irritations. The product is presented in a convenient spray dosage form, allowing for easy application to affected areas. It is designed for topical use and is suitable for various skin types. The active ingredients work synergistically to alleviate discomfort and promote skin healing. The spray is packaged in an aerosol container, ensuring a fine mist for even distribution.

Uses and Indications

This drug is indicated for the temporary alleviation of itching associated with minor skin irritation, inflammation, and rashes resulting from various conditions, including eczema, poison ivy, oak, and sumac exposure, psoriasis, reactions to soaps and detergents, cosmetics, jewelry, insect bites, and seborrheic dermatitis.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The formulation should be shaken well prior to use. For adults and children aged 2 years and older, the medication should be applied to the affected area no more than 3 to 4 times daily. For children under 2 years of age, it is advised to consult a physician before application. When applying to the face, the product should be sprayed into the palm of the hand and then gently applied to the affected area.

Contraindications

Use is contraindicated in the following situations:

• Application in or near the eyes is prohibited. For diaper rash, consult a healthcare professional before use.

• Puncturing or incinerating the product is contraindicated due to the risk of explosion; the contents are under pressure.

• Long-term storage above 104°F is not recommended, as it may compromise product integrity.

• Storage at temperatures exceeding 120°F is contraindicated to prevent potential hazards.

Warnings and Precautions

For external use only. This product is flammable; therefore, it should not be used while smoking or in proximity to heat or open flame. In the event of accidental ingestion, immediate medical assistance should be sought by contacting a poison control center at 1-800-222-1222.

This product is contraindicated for use in or near the eyes. For diaper rash, consultation with a healthcare professional is advised. In cases of accidental exposure to the eyes, it is imperative to rinse the area with water or saline immediately, remove contact lenses if applicable, and seek medical attention for any persistent symptoms. The product should be used strictly as directed, and it is essential not to puncture or incinerate the container, as it is under pressure. Long-term storage should be avoided at temperatures exceeding 104°F, and it should not be stored at temperatures above 120°F.

Healthcare professionals should advise patients to discontinue use and consult a physician if the condition worsens or fails to improve within 7 days, or if symptoms resolve and then recur within a few days. Prior to use, patients should be instructed to consult a healthcare provider if they are currently using any other hydrocortisone or corticosteroid products to avoid potential interactions.

Side Effects

Patients should be aware that the product is for external use only and is flammable; therefore, it should not be used while smoking or near heat or flame.

In clinical practice, it is advised that patients stop using the product and consult a doctor if their condition worsens or does not improve within 7 days, or if the condition clears up and then recurs within a few days.

Additionally, patients are encouraged to seek medical advice before using this product if they are currently using any other hydrocortisone or corticosteroid products, as this may lead to potential interactions or increased risk of adverse effects.

Drug Interactions

Patients should consult a healthcare professional prior to using this medication if they are concurrently using any other hydrocortisone or corticosteroid products. The combination of these agents may lead to an increased risk of adverse effects due to additive pharmacodynamic effects. Monitoring for potential side effects is advised, and dosage adjustments may be necessary based on the clinical scenario and the specific corticosteroid products involved.

Packaging & NDC

Below are the non-prescription pack sizes of Anti Itch. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should be advised to consult a healthcare professional before application, particularly for use on the face. For this age group, it is recommended to spray the product into the palm of the hand and then gently apply it to the skin.

For children aged 2 years and older, the product may be applied to the affected area no more than 3 to 4 times daily. Care should be taken to follow these dosing guidelines to ensure safety and efficacy in this population.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population, given the lack of targeted data.

Pregnancy

There is no specific information regarding the use of this drug during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be counseled on the importance of effective contraception during treatment and the need to inform their healthcare provider if they become pregnant or plan to become pregnant while on this medication.

Lactation

There are no specific warnings or recommendations regarding the use of this product by nursing mothers. Additionally, there are no considerations or precautions mentioned concerning lactation or the potential for excretion in breast milk.

Renal Impairment

Patients with renal impairment may not have specific information regarding dosage adjustments, special monitoring, or safety considerations outlined in the prescribing information. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment and individualized patient assessment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, no dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function are specified in the prescribing information. Healthcare professionals should exercise caution and consider the individual patient's liver function when prescribing this medication.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

Additionally, it is recommended to consult local poison control centers or relevant toxicology resources for guidance on specific management protocols and antidotes, if applicable.

Documentation of the incident, including the substance involved, estimated dose, and time of exposure, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a poison control center at 1-800-222-1222 if the product is swallowed.

Patients should be informed about the importance of avoiding contact with the eyes. In the event of accidental exposure, they should rinse the area with water or saline immediately, remove contact lenses if applicable, and seek medical help if any symptoms persist. It is crucial to emphasize that the product should be used only as directed, and patients should not puncture or incinerate the container, as it is under pressure. Additionally, patients should be cautioned against long-term storage above 104°F and should not store the product at temperatures exceeding 120°F.

Patients should be instructed to discontinue use and consult a doctor if their condition worsens, does not improve within 7 days, or if symptoms clear up and then recur within a few days. Furthermore, healthcare providers should recommend that patients consult a doctor before using this product if they are currently using any other hydrocortisone or corticosteroid products.

Storage and Handling

The product is supplied in various configurations, with specific NDC numbers available for identification. It is essential to adhere to the recommended storage conditions to maintain product integrity.

For optimal storage, the product should be kept at temperatures not exceeding 104°F for extended periods. It is critical to avoid storage at temperatures above 120°F, as this may compromise the product's efficacy and safety.

Additionally, the container must not be punctured or incinerated, as the contents are under pressure. Proper handling and storage practices are vital to ensure the product remains safe and effective for use.

Additional Clinical Information

The medication is administered topically, with the recommended application frequency for adults and children aged 2 years and older being 3 to 4 times daily to the affected area. For children under 2 years of age, it is advised to consult a doctor before application, particularly when applying to the face; in such cases, the product should be sprayed into the palm of the hand and then gently applied.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Anti Itch, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)